Patents by Inventor Marie-Christine Degivry

Marie-Christine Degivry has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ACETOBACTER FOR USE IN PREPARATION OF FERMENTED PRODUCTS
    Publication number: 20240023591
    Abstract: The present invention relates to a novel strain of Acetobacter malorum, compositions comprising said strain and to methods for the preparation of such compositions.
    Type: Application
    Filed: December 3, 2021
    Publication date: January 25, 2024
    Inventors: Laurent MARCHAL, Peggy GARAULT, Marie-Christine DEGIVRY, Christophe DAVAL
  • Strain of ssp.
    Patent number: 10064902
    Abstract: The invention relates to a novel strain of Bifidobacterium animals ssp. animalis, which is able, inter alia, to improve the function of the enteric nervous system, and to compositions said novel strain.
    Type: Grant
    Filed: December 10, 2013
    Date of Patent: September 4, 2018
    Assignee: COMPAGNIE GERVAIS DANONE
    Inventors: Sophie Legrain-Raspaud, Gianfranco Grompone, Sandrine Capronnier, Tamara Smokvina, Marie-Christine Degivry, Biliana Lesic, Michel Neunlist
  • Strain of
    Patent number: 9297049
    Abstract: The invention relates to a new strain of Lactobacillus mucosae which is able to decrease intestinal barrier permeability. This strain is useful in particular for alleviating intestinal barrier dysfunctions.
    Type: Grant
    Filed: December 21, 2011
    Date of Patent: March 29, 2016
    Assignee: Compagnie Gervais Danone
    Inventors: Tamara Smokvina, Marie-Christine Degivry
  • PROBIOTIC STRAINS FOR USE IN IMPROVING THE ENTERIC NERVOUS SYSTEM
    Publication number: 20160045557
    Abstract: The invention relates to the use of lactic acid bacteria, for use in modifying the enteric nervous system and more particularly in treating and/or preventing intestinal disorders such as constipation and/or irritable bowel disease.
    Type: Application
    Filed: October 29, 2015
    Publication date: February 18, 2016
    Applicant: COMPAGNE GERVAIS DANONE
    Inventors: Sophie Legrain-Raspaud, Gianfranco Grompone, Sandrine Capronnier, Isabelle Chambaud, Tamara Smokvina, Marie-Christine Degivry, Biliana Lesic, Michel Neunlist
  • Probiotic strains for use in improving the enteric nervous system
    Patent number: 9198940
    Abstract: The invention relates to the use of lactic acid bacteria, for use in modifying the enteric nervous system and more particularly in treating and/or preventing intestinal disorders such as constipation and/or irritable bowel disease.
    Type: Grant
    Filed: May 27, 2011
    Date of Patent: December 1, 2015
    Assignee: Compagnie Gervais Danone
    Inventors: Sophie Legrain-Raspaud, Gianfranco Grompone, Sandrine Capronnier, Isabelle Chambaud, Tamara Smokvina, Marie-Christine Degivry, Biliana Lesic, Michel Neunlist
  • STRAIN OF BIFIDOBACTERIUM ANIMALIS SSP. ANIMALIS
    Publication number: 20150320807
    Abstract: The invention relates to a novel strain of Bifidobacterium animals ssp. animalis, which is able, inter alia, to improve the function of the enteric nervous system, and to compositions said novel strain.
    Type: Application
    Filed: December 10, 2013
    Publication date: November 12, 2015
    Inventors: Sophie LEGRAIN-RASPAUD, Gianfranco GROMPONE, Sandrine CAPRONNIER, Tamara SMOKVINA, Marie-Christine DEGIVRY, Biliana LESIC, Michel NEUNLIST
  • with anti-oxidant action
    Patent number: 9056123
    Abstract: The present invention relates to specific Lactobacillus strains with an anti-oxidant effect.
    Type: Grant
    Filed: January 8, 2010
    Date of Patent: June 16, 2015
    Assignee: Compagnie Gervais Danone
    Inventors: Gianfranco Grompone, Marie-Christine Degivry, Sophie Legrain-Raspaud, Isabelle Chambaud, Raphaëlle Bourdet-Sicard
  • Novel Strain of Lactobacillus Mucosae
    Publication number: 20140328802
    Abstract: The invention relates to a new strain of Lactobacillus mucosae which is able to decrease intestinal barrier permeability. This strain is useful in particular for alleviating intestinal barrier dysfunctions.
    Type: Application
    Filed: December 21, 2011
    Publication date: November 6, 2014
    Inventors: Tamara Smokvina, Marie-Christine Degivry
  • Method for selecting bacteria with anti-oxidant action
    Patent number: 8735089
    Abstract: The present invention relates to a method using Caenorhabditis elegans for screening of food grade bacteria which have a protective effect against oxidative stress.
    Type: Grant
    Filed: January 8, 2010
    Date of Patent: May 27, 2014
    Assignees: Compagnie Gervais Danone, Biopolis S.L.
    Inventors: Gianfranco Grompone, Marie-Christine Degivry, Daniel Ramon Vidal, Patricia Martorell Guerola, Nuria Gonzalez Martinez, Salvador Genoves Martinez, Sophie Legrain-Raspaud, Isabelle Chambaud, Raphaelle Bourdet-Sicard
  • Probiotic Strains for Use in Improving the Enteric Nervous System
    Publication number: 20130195822
    Abstract: The invention relates to the use of lactic acid bacteria, for use in modifying the enteric nervous system and more particularly in treating and/or preventing intestinal disorders such as constipation and/or irritable bowel disease.
    Type: Application
    Filed: May 27, 2011
    Publication date: August 1, 2013
    Applicant: COMPAGNIE GERVAIS DANONE
    Inventors: Sophie Legrain-Raspaud, Gianfranco Grompone, Sandrine Capronnier, Isabelle Chambaud, Tamara Smokvina, Marie-Christine Degivry, Biliana Lesic, Michel Neunlist
  • Lactobacilli with Anti-Oxidant Action
    Publication number: 20130171117
    Abstract: The present invention relates to specific Lactobacillus strains with an anti-oxidant effect.
    Type: Application
    Filed: January 8, 2010
    Publication date: July 4, 2013
    Inventors: Gianfranco Grompone, Marie-Christine Degivry, Sophie Legrain-Raspaud, Isabelle Chambaud, Raphaëlle Bourdet-Sicard
  • Method for Selecting Bacteria with Anti-Oxidant Action
    Publication number: 20130078187
    Abstract: The present invention relates to a method using Caenorhabditis elegans for screening of food grade bacteria which have a protective effect against oxidative stress.
    Type: Application
    Filed: January 8, 2010
    Publication date: March 28, 2013
    Inventors: Gianfranco Grompone, Marie-Christine Degivry, Daniel Ramon Vidal, Patricia Martorell Guerola, Nuria Gonzalez Martinez, Salvador Genoves Martinez, Sophie Legrain-Raspaud, Isabelle Chambaud, Raphaelle Bourdet-Sicard
  • Lactic acid bacteria with anxiolytic properties and uses thereof
    Patent number: 6541027
    Abstract: The invention concerns lactic acid bacteria with anxiolytic properties and not inducing sedative effect. Said lactic acid bacteria are useful in particular for preparing foods or medicines.
    Type: Grant
    Filed: February 11, 2002
    Date of Patent: April 1, 2003
    Assignee: Compagnie Gervais Danone
    Inventors: Jean-Michel Antoine, Chantal Cayuela, Marie-Christine Degivry, Christian Latge, Eric Postaire
  • Administering bacteria to improve sleep
    Patent number: 6444203
    Abstract: A method of improving sleep in a mammal having a sleep disorder is disclosed. The method includes identifying the mammal having a sleep disorder and then administering Lactobacillus acidophilus CNCM I-2274, Lactobacillus acidophilus CNCM I-2132, Lactobacillus helveticus CNCM I-2275, Streptococcus thermophilus CNCM I-1520, Streptococcus thermophilus CNCM I-2272 or mixtures thereof. The method increases the length of the non rapid eye movement sleep phase and decreases the length of the rapid eye movement sleep phase. The bacteria can be administered in an orally consumable food product or a dietary supplement.
    Type: Grant
    Filed: December 20, 1999
    Date of Patent: September 3, 2002
    Assignee: Compagnie Gervais Danone
    Inventors: James M. Krueger, Michael J. Pabst, Chantal Cayuela, Marie-Christine Degivry, Donna Hartley
  • SOMNOGENIC ACTIVITY
    Publication number: 20010051152
    Abstract: Non-pathogenic lactic acid bacteria have cell walls which are susceptible to digestion by muramidase-type enzymes, which produce fragments referred to as muramylpeptides. The ingestion of muramylpeptides, either directly, or by digestion of non-pathogenic lactic acid bacteria, promote sleep and improves the quality of sleep. In particular, non-rapid eye movement sleep phase is enhanced. The muramylpeptide digestion-products of non-pathogenic lactic acid bacteria promote monocyte production of superoxide anion and the cytokines of IL-1&bgr; and TNF&agr;.
    Type: Application
    Filed: December 20, 1999
    Publication date: December 13, 2001
    Inventors: JAMES M. KRUEGER, MICHAEL J. PABST, CHANTAL CAYUELA, MARIE-CHRISTINE DEGIVRY, DONNA HARTLEY